These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8588080)

  • 1. [Effectiveness of oral immunotherapy in bronchial asthma caused by Dermatophagoides pternyssinus].
    Pacor ML; Biasi D; Carletto A; Lunardi C
    Recenti Prog Med; 1995 Dec; 86(12):489-91. PubMed ID: 8588080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma.
    Sánchez Palacios A; Schamann Medina F; Lamas Rua-Figueroa A; Bosch Millares C; Ramos Santos S; García Marrero JA
    Allergol Immunopathol (Madr); 1989; 17(6):323-9. PubMed ID: 2635834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
    Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accelerated desensitization to Dermatophagoides pteronyssinus mites in children with asthma. Results of two years of immunotherapy].
    Le Roux P; Le Luyer B
    Allerg Immunol (Paris); 1991 Apr; 23(4):135-42. PubMed ID: 2069687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.
    Delaunois L; Salamon E; Prignot J
    Ann Allergy; 1985 Aug; 55(2):150-2. PubMed ID: 4025957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
    Zietkowski Z
    Pol Merkur Lekarski; 1999 May; 6(35):239-41. PubMed ID: 10437390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
    Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mites: the principal respiratory allergens of house dust].
    Bessot JC; Pauli G
    Rev Mal Respir; 1986; 3(1):19-23. PubMed ID: 3715162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of desensitization with Migen of patients with bronchial asthma caused by hypersensitivity to the mite Dermatophagoides pteronyssinus].
    Droszcz W; Lech B; Madalińska M
    Pneumonol Pol; 1978 Aug; 46(8):613-5. PubMed ID: 714704
    [No Abstract]   [Full Text] [Related]  

  • 15. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
    Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
    J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy.
    Moscato G; Rossi G; Dellabianca A; Pisati A; Vinci G; Biale C
    J Investig Allergol Clin Immunol; 1991 Dec; 1(6):383-94. PubMed ID: 1669598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predicting the clinical efficacy of house dust mite immunotherapy in bronchial asthmatics by multiple quantification analysis type II].
    Soda R; Okada C; Takahashi K; Katagi S; Kanehiro A; Kimura G; Okamoto S; Tada S; Kimura I
    Arerugi; 1993 Dec; 42(12):1771-5. PubMed ID: 8110037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do nasal and conjunctival provocation tests represent a trustworthy parameter for the follow-up of childhood IgE-dependent bronchial asthma?].
    Botey J; Eseverri JL; Marin AM
    Allerg Immunol (Paris); 1996 Feb; 28(2):52-4. PubMed ID: 8703310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
    Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
    Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advances of hyposensibilisation therapy in bronchial asthma patients allergic to house dust antigen.
    Romański B; Pawlik K; Wilawska-Kłubo T
    Allerg Immunol (Leipz); 1977; 23(3):211-3. PubMed ID: 147019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.